The vaginal route offers direct access to local tissue, a large surface area for absorption, and the potential to bypass first-pass metabolism—making it an ideal pathway for both local and systemic therapeutic delivery. However, formulating for this route requires deep understanding of:
MedPharm brings this specialized knowledge to every vaginal drug development program we support.
Each formulation is carefully tailored to address your molecule’s characteristics, therapeutic goals, and patient population.
Our team develops and optimizes a wide range of vaginal dosage forms, including:
To accelerate your development program and meet regulatory expectations, MedPharm provides:
With decades of experience in mucosal delivery and topical formulation science, MedPharm is uniquely positioned to help clients develop differentiated vaginal therapies that are safe, effective, and commercially viable. Whether you are entering preclinical development or preparing for late-stage clinical trials, our team provides the scientific rigor and regulatory insight your program demands.